Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 378.7% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $11 | $19 | $6 | $4 |
| G&A Expenses | $13 | $24 | $7 | $5 |
| SG&A Expenses | $13 | $26 | $8 | $7 |
| Sales & Mktg Exp. | $0 | $2 | $1 | $2 |
| Other Operating Expenses | $0 | $0 | -$1 | -$11 |
| Operating Expenses | $24 | $45 | $14 | -$0 |
| Operating Income | -$24 | -$45 | -$14 | -$10 |
| % Margin | -27,661.6% | -250,341.7% | – | – |
| Other Income/Exp. Net | -$23 | $17 | -$35 | -$0 |
| Pre-Tax Income | -$47 | -$28 | -$49 | -$10 |
| Tax Expense | -$2 | $0 | $0 | $0 |
| Net Income | -$47 | -$28 | -$49 | -$10 |
| % Margin | -54,517.4% | -153,825% | – | – |
| EPS | -1.36 | -1.14 | -3.17 | -0.035 |
| % Growth | -19.3% | 64% | -9,061.8% | – |
| EPS Diluted | -1.36 | -1.14 | -3.17 | -0.035 |
| Weighted Avg Shares Out | 34 | 16 | 15 | 298 |
| Weighted Avg Shares Out Dil | 34 | 16 | 15 | 298 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$48 | -$28 | -$14 | -$10 |
| % Margin | -55,920.9% | -154,200% | – | – |